FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, particularly to a method for rapid diagnosis of human chromosomal-integrated betagerpesvirus 6A/B in patient's blood. For this purpose, clinical and laboratory studies are carried out, the viral load of the type of HHV-6A/HHV-6B virus is determined in PCR in whole blood, then at viral load of HHV-6A/B from 4.77 to 5.37 lg copies/105 cells, leukocyte fractions are recovered from blood: lymphocytes, neutrophils, and if HHV-6A/B DNA is detected in lymphocytes and neutrophils, chromosomal integration of the virus is diagnosed, and if HHV-6A/B DNA is detected in lymphocytes, an active infection associated with HHV-6A/B is diagnosed.
EFFECT: invention provides higher accuracy of rapid diagnosis of human chromosome-integrated betagerpesvirus 6A/B in patient's blood due to clinical and laboratory studies.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING AND LABORATORY CONFIRMATION OF INHERITED CHROMOSOMALLY-INTEGRABLE HUMAN HERPES VIRUS 6A/B | 2020 |
|
RU2739997C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
| METHOD FOR EXTRACTION OF NUCLEIC ACIDS FROM NAIL PLATES | 2020 |
|
RU2751244C1 |
| METHOD OF QUANTITATIVE DETERMINATION OF DNA OF HUMAN HERPES VIRUS 6A (HHV-6A) AND A SET OF OLIGONUCLEOTIDE PRIMERS AND A PROBE FOR ITS IMPLEMENTATION | 2022 |
|
RU2802931C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CNS ORGANIC LESIONS IN CHILDREN WITH HERPES VIRAL INFECTIONS | 2019 |
|
RU2729988C1 |
| METHOD OF QUANTITATIVE DETERMINATION OF DNA OF HUMAN HERPES VIRUS 6A (HHV-6A) AND DNA OF HUMAN HERPES VIRUS 6B (HHV-6B) AND A SET OF OLIGONUCLEOTIDE PRIMERS AND A PROBE FOR ITS IMPLEMENTATION | 2022 |
|
RU2800995C1 |
| DIAGNOSTIC TECHNIQUE FOR THE COMBINED INFECTION IN CHILDREN WITH ACUTE RESPIRATORY INFECTIONS | 2019 |
|
RU2706126C1 |
| METHOD FOR EVALUATION OF EFFICIENCY OF TYPE 6 HUMAN HERPES VIRUS INFECTION THERAPY IN CHILDREN | 2016 |
|
RU2646472C1 |
| METHOD OF AETIOLOGICAL VERIFICATION OF CYTOMEGALOVIRUS ENCEPHALITIS IN PATIENTS WITH HIV INFECTION | 2023 |
|
RU2812981C1 |
| METHOD OF QUANTITATIVE DETERMINATION OF DNA OF HUMAN HERPES VIRUS 6A (HHV-6A) AND DNA OF HUMAN HERPES VIRUS 6B (HHV-6B) AND A SET OF OLIGONUCLEOTIDE PRIMERS AND A PROBE FOR ITS IMPLEMENTATION | 2022 |
|
RU2800731C1 |
